Loading Icon

BioMarin Pharmaceutical Inc.

United States

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).

Metrics Summary

Total Publications
Lifetime
733
Prior Five Years
246
Total Citations
Lifetime
16,982
Prior Five Years
3,661
Total Scholars
Lifetime
411
Prior Five Years
267

Non-academic Institutional Ranking

Global Overall (All Fields)

Worldwide

Lifetime
2588
Prior Five Years
N/A
National Overall (All Fields)

United States

Lifetime
323
Prior Five Years
N/A
Institutional Rankings

Fields, Disciplines and Specialties

Lifetime
Prior Five Years

Show More

Publications and Citation History

Publications based on Fields

Scholars based on Fields

Publications based on Top 20 Disciplines

Scholars based on Top 20 Disciplines

Highly Ranked Scholars™

Overall (All Fields)
Lifetime
Field
Lifetime
Discipline
Lifetime
Specialty
Lifetime

Top Scholars by Institution

Highly Cited Publications

Lifetime